Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-14,011
Closed -$214K – 757
2020
Q2
$214K Sell
14,011
-5,722
-29% -$85K 0.02% 659
2020
Q1
$251K Hold
19,733
– – 0.03% 497
2019
Q4
$433K Sell
19,733
-50
-0.3% -$1.14K 0.05% 417
2019
Q3
$453K Hold
19,783
– – 0.05% 419
2019
Q2
$391K Buy
19,783
+4,013
+25% +$93.1K 0.04% 451
2019
Q1
$372K Hold
15,770
– – 0.04% 464
2018
Q4
$351K Sell
15,770
-193
-1% -$4.63K 0.03% 458
2018
Q3
$372K Buy
15,963
+2,772
+21% +$76.9K 0.03% 467
2018
Q2
$356K Sell
13,191
-70
-0.5% -$1.85K 0.03% 528
2018
Q1
$344K Hold
13,261
– – 0.02% 597
2017
Q4
$365K Sell
13,261
-400
-3% -$10.6K 0.02% 612
2017
Q3
$306K Hold
13,661
– – 0.02% 658
2017
Q2
$362K Buy
+13,661
New +$365K 0.02% 570

Other funds holding TBI

Cigna Investments's TBI Position: Q3 2020 in Review

Cigna Investments sold out of Trueblue (TBI) in Q3 2020, closing a stake of 14,011 shares — an estimated $214K sold.

Cigna Investments first reported a position in TBI in Q2 2017 and held it in 13 quarters. The position peaked at $453K in Q3 2019. 158 funds tracked by Wall St. Rank hold TBI as of Q3 2020.

  • Cigna Investments reported no remaining Trueblue position as of Q3 2020 after selling out during the quarter.
  • Cigna Investments sold 14,011 Trueblue shares in Q3 2020, an estimated $214K.
  • Cigna Investments first reported a position in Trueblue in Q2 2017 and held it in 13 quarters.
  • Cigna Investments's Trueblue position peaked at $453K in Q3 2019.
  • 158 funds tracked by Wall St. Rank held Trueblue as of Q3 2020.

Based on Cigna Investments's 13F filing for Q3 2020, filed 12 Nov 2020.